Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106632393B reveals safe scalable PA-824 synthesis avoiding explosive materials ensuring supply chain stability and cost efficiency for global buyers.
Discover a novel Cytosine-based route for Palbociclib parent nucleus. Enhance purity to >99% and reduce costs in pharmaceutical manufacturing with this scalable process.
Patent CN109836383B reveals a novel metal-free route for 3,4-dihydroquinolin-2(1H)-ones, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN105566429B details a novel one-step reduction for high-purity amorphous Obeticholic Acid Form 1, offering significant cost and supply chain advantages.
Novel patent CN114539198B details palladium-catalyzed synthesis offering cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN113278007A details a novel copper-catalyzed route for 2-hydroxy-indole-3-ketones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Novel metal-free synthesis reduces environmental costs. Reliable supply chain for high-purity pharmaceutical intermediates. Scalable oxidation process ensures commercial viability.
Novel metal-free heating-promoted synthesis method for 2-trifluoromethyl quinoline compounds offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113880781B reveals glucose-based triazole synthesis offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN110372653A reveals silver-catalyzed radical cyclization for high-purity selenized benzofuran. Offers cost reduction and scalable supply chain solutions.
Patent CN113880781B reveals glucose-based synthesis. Offers cost and supply chain benefits for pharmaceutical intermediates manufacturing globally.
Advanced 6-step preparation method for CDK4/6 inhibitor SHR6390. Delivers high purity, mild conditions, and cost reduction in API manufacturing for global supply chains.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN110590760B reveals a novel one-pot synthesis for anticancer intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Patent CN114195711B details a novel one-step carbonylation for quinoline-4(1H)-one. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Novel copper-catalyzed one-pot method for 2,3-disubstituted indolines. Reduces steps, enhances purity, ensures supply chain reliability for pharmaceutical manufacturing.
Patent CN109776546B details a high-yield Re-catalyzed synthesis of indolopyrrolones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazole-3-ones. High yield, broad substrate scope, cost-effective API intermediate manufacturing.
Novel iodine-catalyzed reduction method offers high purity intermediates with significant cost and supply chain advantages for pharmaceutical manufacturing processes globally.
Patent CN115772157B reveals cobalt-catalyzed route for 2-alkoxyindoles offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.